SOCS3 can disrupt the SDF-1/CXCR4 pathway [26–28] as well as signaling to either focal adhesion kinase (FAK) or AKT which are both key survival factors induced by IL-6 in CLL. The gene discussed is PTK2; the disease is B-cell chronic lymphocytic leukemia.